carbostyril has been researched along with Pneumonia, Pneumococcal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Bishara, J; Chazan, B; Chowers, M; Cohen-Poradosu, R; Dagan, R; Gerassy-Vainberg, S; Gottesman, BS; Maor, Y; Regev-Yochay, G; Wiener-Well, Y; Zimhony, O | 1 |
| Ambrose, PG; Bhavnani, SM; Drusano, GL; Forrest, A; Hammel, JP; Rubino, CM | 1 |
| Yu, VL | 1 |
| Carbonnelle, S; Lismond, A; Tulkens, PM; Van Bambeke, F | 1 |
| Alfandari, S; Boussekey, N; Chiche, A; Devos, P; Georges, H; Leroy, O; Meybeck, A; Olive, D | 1 |
| Rubinstein, E | 1 |
| Fukuda, Y; Hirakata, Y; Kadota, J; Kohno, S; Miyazaki, Y; Murata, I; Otsu, Y; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
| Fukushima, K; Kakeya, H; Saito, A | 1 |
| Brumpt, I; Grassi, GG | 1 |
| Aubier, M; Geslin, P; Regamey, C; Vercken, JB; Verster, R | 1 |
| Young, LS | 1 |
| Azoulay-Dupuis, E; Bédos, JP; Moine, P; Muffat-Joly, M; Pocidalo, JJ; Vallée, E; Veber, B | 1 |
| Azoulay-Dupuis, E; Bauchet, J; Pocidalo, JJ; Vallée, E | 1 |
| Azoulay-Dupuis, E; Bauchet, J; Bedos, JP; Pocidalo, JJ; Vallee, E; Veber, B | 1 |
| Azoulay-Dupuis, E; Bedos, JP; Hardy, DJ; Pocidalo, JJ; Swanson, RN; Vallée, E | 1 |
2 review(s) available for carbostyril and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
[New quinolones].
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Drug Design; Drug Resistance, Microbial; Humans; Pneumonia, Pneumococcal; Quinolones | 2007 |
Sparfloxacin empirical therapy in community-acquired pneumonia. Results of a meta-analysis of 2 comparative studies.
Topics: Adult; Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Quinolones; Treatment Outcome | 1995 |
1 trial(s) available for carbostyril and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Penicillins; Pneumonia, Pneumococcal; Quinolones; Streptococcus pneumoniae | 1998 |
13 other study(ies) available for carbostyril and Pneumonia, Pneumococcal
| Article | Year |
|---|---|
The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009-2017.
Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cohort Studies; Female; Humans; Israel; Macrolides; Male; Pneumonia, Pneumococcal; Quinolones; Retrospective Studies; Roxithromycin | 2022 |
Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Area Under Curve; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Quinolones; Streptococcus pneumoniae; Treatment Outcome | 2008 |
A clinical solution to antimicrobial resistance in community-acquired pneumonia: narrowing the spectrum of antimicrobial therapy: comment on "Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with communit
Topics: Antigens, Bacterial; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Penicillins; Pneumonia, Pneumococcal; Point-of-Care Systems; Quinolones; Streptococcus pneumoniae | 2011 |
Efflux of novel quinolones in contemporary Streptococcus pneumoniae isolates from community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Biological Transport; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Quinolones; Streptococcus pneumoniae | 2011 |
Severe pneumococcal pneumonia: impact of new quinolones on prognosis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Prognosis; Quinolones; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2011 |
Reply to: Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Levofloxacin; Ofloxacin; Penicillin Resistance; Pneumonia, Pneumococcal; Quinolones; Rabbits; Streptococcus pneumoniae | 2003 |
In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Lung; Male; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Quinolones; Survival Analysis | 2003 |
[Antibiotic therapy in pneumonia. Cave resistance and pneumococcal loopholes].
Topics: Aged; Anti-Bacterial Agents; Diagnosis, Differential; Drug Resistance, Bacterial; Hospitalization; Humans; Macrolides; Penicillins; Pneumonia; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Quinolones; Radiography; Risk Factors; Streptococcus pneumoniae | 2007 |
A new fluoroquinolone for community-acquired pneumonia.
Topics: Anti-Infective Agents; Community-Acquired Infections; Fluoroquinolones; Humans; Pneumonia, Pneumococcal; Quinolones | 1998 |
Pharmacodynamic activities of ciprofloxacin and sparfloxacin in a murine pneumococcal pneumonia model: relevance for drug efficacy.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Female; Fluoroquinolones; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Quinolones; Streptococcus pneumoniae | 1998 |
Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
Topics: Animals; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Fluoroquinolones; Injections, Subcutaneous; Lung; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Pneumonia, Pneumococcal; Quinolones | 1992 |
In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Female; Fluoroquinolones; Leukopenia; Lung; Mice; Mice, Inbred C57BL; Penicillin Resistance; Pneumonia, Pneumococcal; Quinolones; Species Specificity; Streptococcus pneumoniae | 1992 |
Antipneumococcal activity of ciprofloxacin, ofloxacin, and temafloxacin in an experimental mouse pneumonia model at various stages of the disease.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Erythromycin; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred C57BL; Ofloxacin; Pneumonia, Pneumococcal; Quinolones; Sepsis; Streptococcus pneumoniae | 1991 |